Drug discovery takes 10-15 years and costs $2.6B per approved drug. Identifying the right molecular targets and screening compounds efficiently remains the biggest bottleneck in pharmaceutical R&D.

Working with High-Potency APIs requires precise handling classifications, OEL data, and containment strategies. Incomplete safety data leads to occupational exposure risks and costly facility design errors.

Pharmacovigilance teams process thousands of adverse event reports manually. Detecting safety signals early is critical — delays can lead to patient harm, regulatory penalties, and product withdrawals.

Clinical trial and regulatory projects involve hundreds of tasks across multiple teams, sites, and vendors. Traditional project tools lack life sciences-specific features like milestones, deliverables, and regulatory dependencies.

Drug information is scattered across FDA, India drug bank, WHO essential medicines, and other regulatory databases. Comparing drug data across jurisdictions requires manual research across multiple sources.

Pharma executives need answers from vast data sources — research papers, clinical trials, FDA data, patents, market reports. Manual research takes days and often misses critical insights.

Staying current with scientific literature is impossible manually — 250M+ papers exist with 5M+ published annually. Teams miss critical research that could inform drug development decisions.

Identifying the right Key Opinion Leaders for advisory boards, clinical trials, and speaking engagements relies on subjective networks and referrals — missing emerging experts and over-engaging the same KOLs.

Pharmaceutical commercial teams lack real-time visibility into competitive landscapes, pricing benchmarks, and emerging market opportunities — leading to suboptimal launch and pricing decisions.

Tracking competitor drug development pipelines requires monitoring hundreds of clinical trials, regulatory filings, and pipeline changes across multiple sources — missing a single update can mean missing a strategic opportunity.

Regulatory teams must track evolving FDA, EMA, and ICH guidelines across multiple jurisdictions. Missing a regulatory change or deadline can delay submissions by months and cost millions.

Managing clinical trials involves coordinating sites, sponsors, monitoring visits, training, and regulatory documents across multiple systems. Disconnected tools lead to visibility gaps and compliance risks.

Regulatory documents are scattered across shared drives, emails, and local computers. Version control is manual, audit trails are incomplete, and finding the right document for an inspection is a fire drill.

Accessing global health indicators, disease burden data, and mortality statistics requires navigating multiple WHO databases with inconsistent formats and interfaces.

Evaluating a drug's full potential — efficacy, safety, patent landscape, competitive positioning, and market opportunity — requires pulling data from dozens of sources and synthesizing manually.

Pharma operations generate massive data — trial metrics, safety reports, market data, project KPIs. Without AI-powered analytics, teams react to problems instead of predicting them.